Johnson & Johnson (NYSE:JNJ) declared 3Q20 dividend of $ 1.01 per share, or $ 4.04 annualized.
The dividend will be payable on September 8, 2020, to stockholders of record on August 25, 2020, with an ex-dividend date of August 24, 2020.
Dividends History
wpDataTable with provided ID not found!Click Here For More Historical Dividends Of Johnson & Johnson
Stock Performance
According to the previous trading day, closing price of JNJ was $ 149.35, representing a 36.82 % increase from the 52 week low of $ 109.16 and a 4.87 % decrease over the 52 week high of $ 157.00.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”JNJ” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
The company has a market capital of $ 393.84 billion and is part of the Healthcare sector and Drug Manufacturers – Major industry.
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSONS brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.
